INS and Hyperglycemia: GLP-1RAs improve hyperglycemia as well as the insulin sensitivity of the liver and global/local fat, thereby reducing the amount of lipotoxic metabolites and proinflammatory mediators in the circulation, contributing to hepatoprotection against MASLD and MASH [23].